Literature DB >> 14713401

The use of glucosamine therapy in osteoarthritis.

Djamila Zerkak1, Maxime Dougados.   

Abstract

Glucosamine products have been used extensively for the management of pain in osteoarthritis. This paper reviews the most recent clinical and experimental studies regarding its efficacy and safety. Although clinical trials include methodologic flaws and publication bias, glucosamine is likely an effective therapy for the symptomatic management of osteoarthritis. In turn, definite proof for chondromodulating effect requires well-conducted clinical trials. In North America, glucosamine is an over-the-counter dietary supplement and preparations made by different manufacturers may vary. There is also a need to standardize this therapy and allow practitioners to give patients suitable advice. An ongoing long-term clinical trial in the US will possibly permit to investigate the clinical relevance of these results and give appropriate recommendations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713401     DOI: 10.1007/s11926-004-0082-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  38 in total

Review 1.  Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint.

Authors:  J A Chard; D Tallon; P A Dieppe
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  Current status of glucosamine therapy in osteoarthritis.

Authors:  Tanveer E Towheed
Journal:  Arthritis Rheum       Date:  2003-08-15

Review 3.  Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.

Authors:  I Setnikar; L C Rovati
Journal:  Arzneimittelforschung       Date:  2001-09

4.  Glucosamine for osteoarthritis: cure or conundrum?

Authors:  C A Heyneman; R S Rhodes
Journal:  Ann Pharmacother       Date:  1998-05       Impact factor: 3.154

5.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

6.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

7.  Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.

Authors:  J P Rindone; D Hiller; E Collacott; N Nordhaugen; G Arriola
Journal:  West J Med       Date:  2000-02

8.  A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee.

Authors:  R Hughes; A Carr
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

9.  Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.

Authors:  J D Sandy; D Gamett; V Thompson; C Verscharen
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

10.  Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes.

Authors:  G R Dodge; S A Jimenez
Journal:  Osteoarthritis Cartilage       Date:  2003-06       Impact factor: 6.576

View more
  1 in total

1.  Novel oligosaccharide has suppressive activity against human leukemia cell proliferation.

Authors:  O Hosomi; Y Misawa; A Takeya; Y Matahira; K Sugahara; Y Kubohara; F Yamakura; S Kudo
Journal:  Glycoconj J       Date:  2008-08-26       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.